Influenza, Human
Welcome,         Profile    Billing    Logout  
 66 Companies   64 Products   64 Products   38 Mechanisms of Action   0 Trials   1520 News 


«12345678910111213...3031»
  • ||||||||||  oseltamivir / Generic mfg.
    Trial completion, Enrollment change:  Rapid Empiric Treatment With Oseltamivir Study (RETOS) (clinicaltrials.gov) -  Oct 19, 2016   
    P4,  N=1296, Completed, 
    Enrolling by invitation --> Completed | N=1000 --> 1296
  • ||||||||||  lenalidomide / Generic mfg.
    Enrollment closed, Enrollment change, Trial primary completion date:  Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) (clinicaltrials.gov) -  Oct 11, 2016   
    P2,  N=3, Active, not recruiting, 
    N=2000 --> 1524 Recruiting --> Active, not recruiting | N=35 --> 3 | Trial primary completion date: Nov 2017 --> Nov 2018
  • ||||||||||  Trial completion:  Ovarian Cancer and Immune Response to Flu Vaccine (clinicaltrials.gov) -  Oct 5, 2016   
    P=N/A,  N=37, Completed, 
    Recruiting --> Active, not recruiting | N=35 --> 3 | Trial primary completion date: Nov 2017 --> Nov 2018 Recruiting --> Completed
  • ||||||||||  Clinical:  Blood and Plasma Collection For Use in Future Clinical Trials (clinicaltrials.gov) -  Sep 16, 2016   
    P=N/A,  N=200, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Apr 2016 --> Jan 2019
  • ||||||||||  Trial completion, Trial primary completion date:  Licensing Flu Shot Study (clinicaltrials.gov) -  Sep 16, 2016   
    P=N/A,  N=6098, Completed, 
    Trial primary completion date: Apr 2016 --> Jan 2019 Not yet recruiting --> Completed | Trial primary completion date: Jan 2012 --> Oct 2011
  • ||||||||||  Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
    Trial primary completion date:  A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV (clinicaltrials.gov) -  Sep 14, 2016   
    P1/2,  N=170, Active, not recruiting, 
    Not yet recruiting --> Completed | Trial primary completion date: Jan 2012 --> Oct 2011 Trial primary completion date: Apr 2016 --> Jul 2016
  • ||||||||||  Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
    Trial primary completion date:  Flu Vaccine Against Childhood Pneumonia, Bangladesh (clinicaltrials.gov) -  Aug 31, 2016   
    P3,  N=3508, Recruiting, 
    Suspended --> Completed Trial primary completion date: Oct 2015 --> Apr 2017
  • ||||||||||  Trial completion, Trial initiation date, Trial primary completion date:  The Effect of Time-Slot Scheduling on Flu Vaccination Rates (clinicaltrials.gov) -  Aug 17, 2016   
    P=N/A,  N=50000, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed | Initiation date: Sep 2010 --> Sep 2009 | Trial primary completion date: Nov 2010 --> Jul 2012
  • ||||||||||  Enrollment change, Real-world evidence, Real-world:  MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (clinicaltrials.gov) -  Aug 16, 2016   
    P=N/A,  N=907, Completed, 
    Not yet recruiting --> Completed | Initiation date: Sep 2010 --> Sep 2009 | Trial primary completion date: Nov 2010 --> Jul 2012 N=728 --> 907
  • ||||||||||  Trial completion:  H7N9 Mix and Match With MF59 in Healthy Elderly Persons (clinicaltrials.gov) -  Aug 15, 2016   
    P2,  N=479, Completed, 
    N=150 --> 98 Active, not recruiting --> Completed
  • ||||||||||  Flucelvax (influenza virus trivalent vaccine) / CSL Behring
    Enrollment change, Trial withdrawal:  Flucelvax Pregnancy Registry (clinicaltrials.gov) -  Aug 12, 2016   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed N=600 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Ampligen (rintatolimod) / AIM ImmunoTech
    Trial primary completion date:  Safety Study of FluMist With and Without Ampligen (clinicaltrials.gov) -  Aug 9, 2016   
    P1/2,  N=72, Active, not recruiting, 
    N=600 --> 0 | Recruiting --> Withdrawn Trial primary completion date: Jun 2016 --> Jun 2017
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Testing the AVI-7100 Flu Drug in Healthy Volunteers (clinicaltrials.gov) -  Jul 1, 2016   
    P1,  N=66, Completed, 
    Trial primary completion date: Dec 2016 --> Jun 2017 Active, not recruiting --> Completed | N=50 --> 66 | Trial primary completion date: Nov 2016 --> Jun 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults (clinicaltrials.gov) -  May 13, 2016   
    P1,  N=100, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2011 --> Jul 2011
  • ||||||||||  Remicade (infliximab) / J&J
    Trial completion, Enrollment change:  Infliximab IBD Influenza Vaccine Study (clinicaltrials.gov) -  May 9, 2016   
    P=N/A,  N=137, Completed, 
    Active, not recruiting --> Recruiting Not yet recruiting --> Completed | N=180 --> 137
  • ||||||||||  Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
    Enrollment closed, Enrollment change, Trial primary completion date, Adverse events:  IVVE:Pilot: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (clinicaltrials.gov) -  May 5, 2016   
    P4,  N=600, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=3500 --> 600 | Trial primary completion date: Dec 2019 --> Dec 2016